RT Journal Article SR Electronic T1 Targeting the gut microbiome in allogeneic hematopoietic stem cell transplantation JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.04.08.20058198 DO 10.1101/2020.04.08.20058198 A1 Marcel A. de Leeuw A1 Manuel X. Duval YR 2020 UL http://medrxiv.org/content/early/2020/06/09/2020.04.08.20058198.abstract AB Background Gut microbiota (GM) composition has been associated with acute Graft-versus-Host Disease (aGvHD), however, current knowledge is insufficient to target the GM.Methods A relevant series of microbiome data sets were combined and reanalyzed, with resolution of species level changes in the GM.Results GM composition was found strongly correlated with aGvHD status after one month post stem cell infusion (R2=0.51). The predicted average biological safety level, indicative of antibiotic resistance, was found increased in aGvHD cases (p=1.6E-4). Using in silico modelling, we formulated a probiotic composition putatively competing with mortality and aGvHD associated species.Implications Supplementation with Bifidobacterium longum and Bifidobacterium breve is proposed as a prophylactic treatment alongside with prebiotics and an adapted antibiotics course.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors did not receive funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and ananlysis scripts have been made available under Github. https://github.com/GeneCreek/GvHD-manuscript